Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 9
Submit an article Journal homepage
1,687
Views
16
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Proton therapy in the management of non-Hodgkin lymphoma

Suzanne SachsmanUniversity of Florida Proton Therapy Institute, Jacksonville, FL, USA
,
Stella FlampouriUniversity of Florida Proton Therapy Institute, Jacksonville, FL, USA
,
Zuofeng LiUniversity of Florida Proton Therapy Institute, Jacksonville, FL, USA
,
James LynchDepartment of Hematology and Oncology, University of Florida, College of Medicine, Gainesville, FL, USA
,
Nancy P. MendenhallUniversity of Florida Proton Therapy Institute, Jacksonville, FL, USA
&
Bradford S. HoppeUniversity of Florida Proton Therapy Institute, Jacksonville, FL, USACorrespondence[email protected]
Pages 2608-2612 | Received 14 Nov 2014, Accepted 26 Jan 2015, Published online: 18 May 2015

References

  • Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Non-Hodgkin Lymphoma. 2014. Available from: http://seer.cancer.gov/statfacts/html/nhl.html
  • Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 2011;100:86–92.
  • Specht L, Yahalom J, Illidge T, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 2014;89:854–62.
  • Bi XW, Li YX, Fang H, et al. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome. Int J Radiat Oncol Biol Phys 2013;87:1086–1093.
  • Xu LM, Li YX, Fang H, et al. Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma. Int J Radiat Oncol Biol Phys 2013;85:1289–1295.
  • Holtzman A, Hoppe BS, Li Z, et al. Advancing the therapeutic index in stage III/IV pediatric Hodgkin lymphoma with proton therapy. Int J Particle Ther 2014;1:343–356.
  • Hoppe BS, Flampouri S, Su Z, et al. Consolidative involved-node proton therapy for stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a phase II study. Int J Radiat Oncol Biol Phys 2012;83:260–267.
  • Hoppe BS, Flampouri S, Zaiden R, et al. Involved-node proton therapy in combined modality therapy for hodgkin lymphoma: results of a phase 2 study. Int J Radiat Oncol Biol Phys 2014;89:1053–1059.
  • Illidge T, Specht L, Yahalom J, et al. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2014;89:49–58.
  • Parikh RR, Moskowitz BK, Maher E, et al. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy. Leuk Lymphoma 2015 Jan 28. [Epub ahead of print]
  • Sachsman S, Flampouri S, Li Z, Lynch J, Mendenhall NP, Hoppe BS, et al. Proton therapy in the management of non-hodgkin lymphoma. Leuk Lymphoma 2015:1–20. [Epub ahead of print] PubMed PMID: 25669925.
  • Chen Y, Adams J, Abramson JS, et al. Preliminary experience with proton radiotherapy in mediastinal lymphoma. Int J Radiat Oncol Biol Phys 2010;78(3, Suppl.):S547.
  • Li J, Dabaja B, Reed V, et al. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys 2011;81:167–174.
  • Hoppe B, Flampouri S, Dang N, et al. Advantages of Proton therapy in the management of primary mediastinal B-cell lymphoma (PMBCL). Br J Haematol 2012;159(Suppl. 1): Abstract 61.
  • Ronson B, Rossi C, Johnson S, et al. Locoregional proton radiotherapy of a primary cavernous sinus non-Hodgkin’s lymphoma: case report. Technol Cancer Res Treat 2006;5:281–284.
  • Chung CS, Yock TI, Nelson K, et al. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 2013;87:46–52.
  • Hoppe BS, Flampouri S, Su Z, et al. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2012;84:449–455.
  • Dunleavy K, Pittaluga S, Maeda LS, et al. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med 2013;368:1408–1416.
  • Bhatia S, Paulino AC, Buatti JM, et al. Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 2002;54:818–823.
  • Bolek TW, Moyses HM, Marcus RB Jr, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999;44:31–36.
  • Zhou P, Ng AK, Silver B, et al. Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys 2005;63:866–871.
  • Fasola CE, Jones JC, Huang DD, et al. Low-dose radiation therapy (2 Gy x 2) in the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys 2013;86:930–935.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.